
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MKP-3 CRISPR/Cas9 KO Plasmid (h) | sc-400850 | 20 µg | $397.00 |
DUSP6 encodes the dual-specificity phosphatase MKP-3, a cytosolic MAPK phosphatase that preferentially dephosphorylates and inactivates ERK1/2 (MAPK3/MAPK1) to shape the magnitude and duration of RTK–RAS–RAF–MEK–ERK signaling. By providing negative feedback on ERK activity, MKP-3 influences cell proliferation, differentiation, and stress-response programs, and helps maintain signaling homeostasis in contexts driven by growth factor cues such as FGFR and EGFR pathways. Altered DUSP6 expression or activity has been linked to dysregulated MAPK signaling observed across multiple disease-relevant settings, including oncogenic pathway activation, inflammatory responses, and developmental phenotypes. As a pathway gatekeeper, MKP-3 is commonly studied for its role in feedback control, signaling adaptation, and ERK-dependent transcriptional outputs.
MKP-3 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the DUSP6 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the DUSP6 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the DUSP6 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MKP-3 protein expression.
This CRISPR knockout system enables efficient generation of DUSP6-deficient cell models for investigation of MKP-3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.